AmeriStart

AmeriStart was a specialized Contract Research Organization (CRO) that provided clinical trial start-up services, including site identification, feasibility studies, and patient recruitment. Founded to streamline the initial phases of clinical research, the company focused on accelerating the timeline from protocol development to the first patient enrolled. In 2013, AmeriStart was acquired by SynteractHCR (now Synteract, a Syneos Health company) to enhance its global clinical trial capabilities and site management services. The integration allowed SynteractHCR to leverage AmeriStart's expertise in site relationships and recruitment strategies across various therapeutic areas. The company's services were designed to help pharmaceutical and biotechnology firms reduce the time and cost associated with the early stages of clinical development.